Solar eclipse didn’t increase hospital admissions

Hospitals across the U.S. prepared for a rush of patients who might be blinded by looking directly at the sun during Monday’s solar eclipse—but the rush never came.

STAT News says the preparations ranged from canceling elective surgeries and increasing emergency and acute care staff by nearly 40 percent in Oregon’s St. Charles Health System to several weeks of training for clinicians at Red Bud Regional Hospital in Illinois.

“The big thing we worry about is solar retinopathy, which is just [ultraviolet] light burning the retina,” said Ali Raja, MD, an emergency medicine physician at Massachusetts General Hospital.

While Raja and others saw people, including healthcare professionals, ignore warnings and stare directly at the sun without eye protection, patient volumes was light in the hours following the eclipse.

Read the full article at the link below:

""
John Gregory, Senior Writer

John joined TriMed in 2016, focusing on healthcare policy and regulation. After graduating from Columbia College Chicago, he worked at FM News Chicago and Rivet News Radio, and worked on the state government and politics beat for the Illinois Radio Network. Outside of work, you may find him adding to his never-ending graphic novel collection.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.